BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29938857)

  • 1. Assessments of tumor metabolism with CEST MRI.
    Goldenberg JM; Pagel MD
    NMR Biomed; 2019 Oct; 32(10):e3943. PubMed ID: 29938857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Evaluations of pH and Enzyme Activity with a CEST MRI Contrast Agent.
    Kombala CJ; Lokugama SD; Kotrotsou A; Li T; Pollard AC; Pagel MD
    ACS Sens; 2021 Dec; 6(12):4535-4544. PubMed ID: 34856102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multislice CEST MRI improves the spatial assessment of tumor pH.
    Randtke EA; Granados JC; Howison CM; Pagel MD; Cárdenas-Rodríguez J
    Magn Reson Med; 2017 Jul; 78(1):97-106. PubMed ID: 27465207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor pH Imaging Using Chemical Exchange Saturation Transfer (CEST)-MRI.
    Longo DL; Pirotta E; Gambino R; Romdhane F; Carella A; Corrado A
    Methods Mol Biol; 2023; 2614():287-311. PubMed ID: 36587132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatine CEST MRI for Differentiating Gliomas with Different Degrees of Aggressiveness.
    Cai K; Tain RW; Zhou XJ; Damen FC; Scotti AM; Hariharan H; Poptani H; Reddy R
    Mol Imaging Biol; 2017 Apr; 19(2):225-232. PubMed ID: 27541025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of in vivo enzyme activity with CatalyCEST MRI.
    Yoo B; Sheth VR; Howison CM; Douglas MJ; Pineda CT; Maine EA; Baker AF; Pagel MD
    Magn Reson Med; 2014 Mar; 71(3):1221-30. PubMed ID: 23640714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH.
    Lindeman LR; Randtke EA; High RA; Jones KM; Howison CM; Pagel MD
    Magn Reson Med; 2018 May; 79(5):2766-2772. PubMed ID: 29024066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A machine learning approach that measures pH using acidoCEST MRI of iopamidol.
    Li T; Cárdenas-Rodríguez J; Trakru PN; Pagel MD
    NMR Biomed; 2023 Oct; 36(10):e4986. PubMed ID: 37280721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI.
    Sinharay S; Randtke EA; Jones KM; Howison CM; Chambers SK; Kobayashi H; Pagel MD
    Magn Reson Med; 2017 May; 77(5):2005-2014. PubMed ID: 27221386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy.
    Hoffmann E; Schache D; Höltke C; Soltwisch J; Niland S; Krähling T; Bergander K; Grewer M; Geyer C; Groeneweg L; Eble JA; Vogl T; Roth J; Heindel W; Maus B; Helfen A; Faber C; Wildgruber M; Gerwing M; Hoerr V
    J Transl Med; 2023 Aug; 21(1):577. PubMed ID: 37641066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.
    McVicar N; Li AX; Meakin SO; Bartha R
    NMR Biomed; 2015 May; 28(5):566-75. PubMed ID: 25808190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T.
    Harris RJ; Cloughesy TF; Liau LM; Nghiemphu PL; Lai A; Pope WB; Ellingson BM
    NMR Biomed; 2016 Nov; 29(11):1563-1576. PubMed ID: 27717216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single diamagnetic catalyCEST MRI contrast agent that detects cathepsin B enzyme activity by using a ratio of two CEST signals.
    Hingorani DV; Montano LA; Randtke EA; Lee YS; Cárdenas-Rodríguez J; Pagel MD
    Contrast Media Mol Imaging; 2016; 11(2):130-8. PubMed ID: 26633584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Nanoscale Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agent That Measures pH.
    Kombala CJ; Kotrotsou A; Schuler FW; de la Cerda J; Ma JC; Zhang S; Pagel MD
    ACS Nano; 2021 Dec; 15(12):20678-20688. PubMed ID: 34870957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative description of radiofrequency (RF) power-based ratiometric chemical exchange saturation transfer (CEST) pH imaging.
    Wu R; Longo DL; Aime S; Sun PZ
    NMR Biomed; 2015 May; 28(5):555-65. PubMed ID: 25807919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for accurate pH mapping with chemical exchange saturation transfer (CEST) MRI.
    Sun PZ; Xiao G; Zhou IY; Guo Y; Wu R
    Contrast Media Mol Imaging; 2016 May; 11(3):195-202. PubMed ID: 26689424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive Investigation of Tumor Metabolism and Acidosis by MRI-CEST Imaging.
    Consolino L; Anemone A; Capozza M; Carella A; Irrera P; Corrado A; Dhakan C; Bracesco M; Longo DL
    Front Oncol; 2020; 10():161. PubMed ID: 32133295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting in vivo urokinase plasminogen activator activity with a catalyCEST MRI contrast agent.
    Sinharay S; Howison CM; Baker AF; Pagel MD
    NMR Biomed; 2017 Jul; 30(7):. PubMed ID: 28370884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxation-compensated CEST-MRI at 7 T for mapping of creatine content and pH--preliminary application in human muscle tissue in vivo.
    Rerich E; Zaiss M; Korzowski A; Ladd ME; Bachert P
    NMR Biomed; 2015 Nov; 28(11):1402-12. PubMed ID: 26374674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.
    Bagga P; Haris M; D'Aquilla K; Wilson NE; Marincola FM; Schnall MD; Hariharan H; Reddy R
    J Transl Med; 2017 May; 15(1):119. PubMed ID: 28558795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.